COGT

Cogent Biosciences, Inc.

6 catalysts on file

COGT

Cogent Biosciences, Inc.

Phase 2 AI-extracted

bezuclastinib

NonAdvanced Systemic Mastocytosis (NonAdvSM)

218d ago Dec 1, 2025

SEC 8-K verified 13h ago

Countdown card →

COGT

Cogent Biosciences, Inc.

AdCom AI-extracted

bezuclastinib

GIST who have received prior treatment with imatinib

187d ago Jan 1, 2026

SEC 8-K verified 13h ago

Countdown card →

COGT

Cogent Biosciences, Inc.

Phase 3 Confirmed

bezuclastinib

Gastrointestinal Stromal Tumor

38d ago May 30, 2026

SEC 8-K verified 13h ago

Countdown card →

COGT

Cogent Biosciences, Inc.

Approval AI-extracted

bezuclastinib

GIST who have received prior treatment with imatinib

7d ago Jun 30, 2026

SEC 8-K verified 13h ago

Countdown card →

COGT

Cogent Biosciences, Inc.

PDUFA Confirmed

bezuclastinib

NonAdvanced Systemic Mastocytosis

T-minus 176 days Dec 30, 2026

SEC 8-K verified 13h ago

Countdown card →

COGT

Cogent Biosciences, Inc.

CRL AI-extracted

bezuclastinib

GIST who have received prior treatment with imatinib

Date TBD Date TBD

SEC 8-K verified 13h ago

Countdown card →